Design and tests of an HIV vaccine.

Design and tests of an HIV vaccine.

It is likely that a successful vaccine against HIV will need to stimulate the innate immune system, generate high levels of neutralising antibody, strong cellular immune responses, and mucosal immunity. Early efforts to develop HIV vaccines attempted to use the virus glycoprotein, gp120, to induce n...

Cur síos iomlán

Sonraí bibleagrafaíochta
Príomhchruthaitheoirí:	McMichael, A, Mwau, M, Hanke, T
Formáid:	Journal article
Teanga:	English
Foilsithe / Cruthaithe:	2002

Míreanna comhchosúla

HIV T cell vaccines, the importance of clades.
de réir: McMichael, A, et al.
Foilsithe / Cruthaithe: (2002)

Design and validation of an enzyme-linked immunospot assay for use in clinical trials of candidate HIV vaccines.
de réir: Mwau, M, et al.
Foilsithe / Cruthaithe: (2002)

A review of vaccines for HIV prevention.
de réir: Mwau, M, et al.
Foilsithe / Cruthaithe: (2003)

Is an HIV vaccine possible?
de réir: Mcmichael, A, et al.
Foilsithe / Cruthaithe: (1999)

HIV vaccines 1983-2003.
de réir: Mcmichael, A, et al.
Foilsithe / Cruthaithe: (2003)

Design and construction of an experimental HIV-1 vaccine for a year-2000 clinical trial in Kenya.
de réir: Hanke, T, et al.
Foilsithe / Cruthaithe: (2000)

New templates for HIV-1 antibody-based vaccine design.
de réir: Sattentau, Q, et al.
Foilsithe / Cruthaithe: (2010)

HIV vaccines.
de réir: Mcmichael, A
Foilsithe / Cruthaithe: (2006)

DNA multi-CTL epitope vaccines for HIV and Plasmodium falciparum: immunogenicity in mice.
de réir: Hanke, T, et al.
Foilsithe / Cruthaithe: (1998)

Future vaccines for HIV.
de réir: Blanchard, T, et al.
Foilsithe / Cruthaithe: (1996)

Unusual antigen presentation offers new insight into HIV vaccine design
de réir: McMichael, A, et al.
Foilsithe / Cruthaithe: (2017)

HIV-1 vaccines: let's get physical.
de réir: Goonetilleke, N, et al.
Foilsithe / Cruthaithe: (2013)

Comment on clinical development of candidate HIV vaccines: different problems for different vaccines.
de réir: McMichael, A, et al.
Foilsithe / Cruthaithe: (2014)

The 2nd generation of a T-cell vaccine against HIV based on conserved region mosaics
de réir: Ondondo, B, et al.
Foilsithe / Cruthaithe: (2014)

On the growing complexity of HIV-1 vaccines
de réir: Hanke, T
Foilsithe / Cruthaithe: (2010)

Prospect of a prophylactic vaccine for HIV.
de réir: Hanke, T
Foilsithe / Cruthaithe: (2001)

The importance of cellular immune response to HIV: implications for antibody production and vaccine design
de réir: Brenna, E, et al.
Foilsithe / Cruthaithe: (2021)

HIV-host interactions: implications for vaccine design
de réir: Haynes, B, et al.
Foilsithe / Cruthaithe: (2016)

The quest for an AIDS vaccine: is the CD8+ T-cell approach feasible?
de réir: McMichael, A, et al.
Foilsithe / Cruthaithe: (2002)

The dynamics of the cellular immune response to HIV infection: implications for vaccination.
de réir: Mcmichael, A, et al.
Foilsithe / Cruthaithe: (2000)

Development of a DNA-MVA/HIVA vaccine for Kenya.
de réir: Hanke, T, et al.
Foilsithe / Cruthaithe: (2002)

Design and pre-clinical evaluation of a universal HIV-1 vaccine.
de réir: Létourneau, S, et al.
Foilsithe / Cruthaithe: (2007)

New templates for HIV-1 antibody-based vaccine design
de réir: Sattentau, Q, et al.
Foilsithe / Cruthaithe: (2010)

Developing HIV-1 vaccines with a positive attitude
de réir: Hanke, T
Foilsithe / Cruthaithe: (2008)

Pre-clinical development of a multi-CTL epitope-based DNA prime MVA boost vaccine for AIDS.
de réir: Hanke, T, et al.
Foilsithe / Cruthaithe: (1999)

Effective induction of HIV-specific CTL by multi-epitope using gene gun in a combined vaccination regime.
de réir: Hanke, T, et al.
Foilsithe / Cruthaithe: (1999)

STEP trial and HIV-1 vaccines inducing T-cell responses.
de réir: Hanke, T
Foilsithe / Cruthaithe: (2008)

HIV-1: from escapism to conservatism.
de réir: Hanke, T, et al.
Foilsithe / Cruthaithe: (2011)

A human immunodeficiency virus 1 (HIV-1) clade A vaccine in clinical trials: stimulation of HIV-specific T-cell responses by DNA and recombinant modified vaccinia virus Ankara (MVA) vaccines in humans.
de réir: Mwau, M, et al.
Foilsithe / Cruthaithe: (2004)

MVA as a vector for vaccines against HIV-1.
de réir: Im, E, et al.
Foilsithe / Cruthaithe: (2004)

Is a human CD8 T-cell vaccine possible, and if so, what would it take? Could a CD8+ T-cell vaccine prevent persistent HIV infection?
de réir: McMichael, A
Foilsithe / Cruthaithe: (2017)

Novel HIV-1 clade B candidate vaccines designed for HLA-B*5101(+) patients protected mice against chimaeric ecotropic HIV-1 challenge.
de réir: Roshorm, Y, et al.
Foilsithe / Cruthaithe: (2009)

In pursuit of an HIV vaccine: an interview with Andrew McMichael.
de réir: Mcmichael, A
Foilsithe / Cruthaithe: (2013)

Biodistribution and persistence of an MVA-vectored candidate HIV vaccine in SIV-infected rhesus macaques and SCID mice.
de réir: Hanke, T, et al.
Foilsithe / Cruthaithe: (2005)

Anti-HIV cellular immunity: recent advances towards vaccine design.
de réir: Goulder, P, et al.
Foilsithe / Cruthaithe: (1999)

The HIVconsv Vaccines Induce Polyfunctional and Highly Proliferative T Cells that Control In Vitro HIV Replication: HIV-CORE002 Phase-I Clinical Trial
de réir: Ondondo, B, et al.
Foilsithe / Cruthaithe: (2013)

Conserved immunogens in prime-boost strategies for the next-generation HIV-1 vaccines.
de réir: Hanke, T
Foilsithe / Cruthaithe: (2014)

Phase I Clinical Trial HIV-CORE002 of a Universal T-cell Vaccine: One Year Follow On and Epitope Mapping
de réir: Borthwick, N, et al.
Foilsithe / Cruthaithe: (2013)

PedVACC 001 and 002: building foundations for infant HIV-1 vaccine trials against breast milk transmission of HIV-1
de réir: Hanke, T
Foilsithe / Cruthaithe: (2012)

pTHr.HIVA and MVA.HIVA vaccines (gag p24/p17) augment CD4+T cell responses in chronically infected HIV-1 patients on HAART
de réir: Ondondo, B, et al.
Foilsithe / Cruthaithe: (2005)